Adérson Omar Mourão Cintra Damião

Author

Also Known As

A Damiao, A Damião, A O Damião, A O M C Damiao, A O M C Damião, A. Damiao, A. O. M. C. Damião, A.O.M.C. Damião, Aderson Damiao, Aderson Damião

142

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

Universidade de São Paulo Universidade Estadual de Campinas (UNICAMP)Universidade do Oeste de Santa Catarina Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo University of Calgary

About

Adérson Omar Mourão Cintra Damião is an author at Universidade de São Paulo specializing in medicine, gastroenterology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	159
2	Gastroenterology	5	5	159
3	Pathology	3	3	99
4	Health Sciences	2	2	53
5	Immunology	2	2	68

Adérson Omar Mourão Cintra Damião

Publications

641

Citations

H-Index

Page 1

	Year	Citations
Safety and efficacy of tofacitinib for treatment of ulcerative colitis: final analysis of OCTAVE Open, an open‐label, long‐term extension study with up to 7.0 years of treatment William J. Sandborn, Nervin Lawendy, Silvio Danese, Alimentary Pharmacology & Therapeutics	2021	146
Histologic Study of Colonic Mucosa in Patients With Chronic Diarrhea and Normal Colonoscopic Findings José Guilherme Nogueira da Silva, Thales de Brito, Adérson Omar Mourão Cintra Damião, Journal of Clinical Gastroenterology	2005	89
Risk of thrombosis and mortality in inflammatory bowel disease Adriana Ribas Andrade, Luísa Leite Barros, Matheus Freitas Cardoso de Azevedo, Clinical and Translational Gastroenterology	2018	66
Differential expression of interleukin 1 receptor antagonist isoforms in human intestinal epithelial cells Ulrich Böcker, Adérson Omar Mourão Cintra Damião, Lisa Holt, Gastroenterology InflammationCytokineAutoimmune DiseaseDifferential ExpressionReceptor Antagonist Isoforms	1998	46
Temporal trends in the epidemiology of inflammatory bowel diseases in the public healthcare system in Brazil: A large population-based study Abel Botelho Quaresma, Adérson Omar Mourão Cintra Damião, Cláudio Saddy Rodrigues Coy, The Lancet Regional Health - Americas	2022	42
Gallbladder Hypokinesia in Crohn’s Disease Adérson Omar Mourão Cintra Damião, Aytan Miranda Sipahi, Denise Cerqueira Paranaguá‐Vezozzo, Digestion Eus-guided Gallbladder DrainageBody CompositionHealth SciencesBiliary TractGallbladder Volume	1997	39
Ursodeoxycholic Acid Ameliorates Experimental Ileitis Counteracting Intestinal Barrier Dysfunction and Oxidative Stress Carlos Felipe Bernardes-Silva, Adérson Omar Mourão Cintra Damião, Aytan Miranda Sipahi, Digestive Diseases and Sciences MedicinePhysiologyGastroenterologyDigestive TractUlcerative Colitis	2004	38
Clinical manifestations, treatment, and outcomes of children and adolescents with eosinophilic esophagitis Maraci Rodrigues, Maria Fernanda M. D’Amico, Fatima Regina Almeida Patiño, Jornal de Pediatria	2013	25
Long-term effectiveness and safety of ustekinumab in bio-naïve and bio-experienced anti-tumor necrosis factor patients with Crohn’s disease: a real-world multicenter Brazilian study Rogério Serafim Parra, Júlio Maria Fonseca Chebli, Natália Sousa Freitas Queiroz, BMC Gastroenterology	2022	23
DOP61 Tofacitinib, an oral, small-molecule Janus kinase inhibitor, in the treatment of ulcerative colitis: Analysis of an open-label, long-term extension study with up to 5.9 years of treatment Gary R. Lichtenstein, Edward V. Loftus, Shu‐Chen Wei, Journal of Crohn s and Colitis InflammationAbstract Background TofacitinibAnti-inflammatoryAutoimmune DiseaseGastrointestinal Pharmacology	2020	22

Page 1